Identification of ( 20R )‐protopanaxadiol from Panax ginseng as a novel anti‐ SARS ‐ CoV ‐2 compound
FEBS Open Bio · 21.07.2026
DOI: 10.1002/2211-5463.70307 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, online erschienen am 21.07.2026. Verfasst von Midori Takeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biological Information Technology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
COVID‐19 remains a global health concern, yet current antivirals are restricted to high‐risk patients and face issues of resistance. To establish a safer evaluation system, we constructed a noninfectious SARS‐CoV‐2 replicon using a BAC vector driven by the CMV promoter. Among the tested cell lines, HuH‐7.6c supported the most efficient replication. Replication was inhibited by remdesivir, nirmatrelvir, and molnupiravir, but not by favipiravir or AT‐527. A screening of 373 food‐derived compounds identified (20R)‐protopanaxadiol (PPD), a ginseng metabolite, as a novel inhibitor. Together, this work highlights this BAC‐vectored replicon as a practical platform for antiviral screening and identifies the potential of safe, food‐derived supplements in combating SARS‐CoV‐2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biological Information Technology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
ORCID-Profile: Masanori Ikeda
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Takeda, M., Maezono, N., Uchikoshi, R., Kato, N., & Ikeda, M. (2026). Identification of ( 20R )‐protopanaxadiol from Panax ginseng as a novel anti‐ SARS ‐ CoV ‐2 compound. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70307
Vancouver
Takeda M, Maezono N, Uchikoshi R, Kato N, Ikeda M. Identification of ( 20R )‐protopanaxadiol from Panax ginseng as a novel anti‐ SARS ‐ CoV ‐2 compound. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70307
BibTeX
@article{Takeda2026,
author = {Takeda, Midori and Maezono, Natsue and Uchikoshi, Rina and Kato, Nobuyuki and Ikeda, Masanori},
title = {Identification of ( 20R )‐protopanaxadiol from Panax ginseng as a novel anti‐ SARS ‐ CoV ‐2 compound},
journal = {FEBS Open Bio},
year = {2026},
doi = {10.1002/2211-5463.70307}
}
EUVIMED